product summary
Loading...
company name :
R&D Systems
product type :
other
product name :
Cultrex RGF Basement Membrane Extract, Type 2
catalog :
3533-010-02
quantity :
10 mL (2 x 5 mL)
price :
446 USD
more info or order :
citations: 72
Reference
Pozzo E, Yedigaryan L, Giarratana N, Wang C, Garrido G, Degreef E, et al. miR-449a/miR-340 reprogram cell identity and metabolism in fusion-negative rhabdomyosarcoma. Cell Rep. 2025;44:115171 pubmed publisher
Hierlmayer S, Hladchenko L, Reichenbach J, Klein C, Mahner S, Trillsch F, et al. Establishment of Stable Knockdown of MACC1 Oncogene in Patient-Derived Ovarian Cancer Organoids. Methods Protoc. 2024;7: pubmed publisher
Schughart K, M xf6 ller Kerutt A, H xf6 ffken V, Nedvetsky P, Groh A, Braun D, et al. PALS1-dependent modulations of mRNA profiles in MDCK II cells grown in non-confluent monolayers and three-dimensional cysts. BMC Genom Data. 2024;25:102 pubmed publisher
Guo S, Liu Z, Wang G, Sun Z, Yu K, Fawcett J, et al. KANK1 promotes breast cancer development by compromising Scribble-mediated Hippo activation. Nat Commun. 2024;15:10381 pubmed publisher
Lu H, Liu H, Yan R, Ma W, Liu H, Liu R, et al. Carbonic anhydrase 2 facilitates sorafenib resistance by counteracting MCT4-mediated intracellular pH dysregulation in HCC. Cell Rep. 2024;43:114996 pubmed publisher
Carleton N, Lee S, Li R, Zou J, Brown D, Hooda J, et al. Systemic and local chronic inflammation and hormone disposition promote a tumor-permissive environment for breast cancer in older women. bioRxiv. 2024;: pubmed publisher
Uroz M, Stoddard A, Sutherland B, Courbot O, Oria R, Li L, et al. Differential stiffness between brain vasculature and parenchyma promotes metastatic infiltration through vessel co-option. Nat Cell Biol. 2024;26:2144-2153 pubmed publisher
Liu Y, Li J, Xu J, Long Y, Wang Y, Liu X, et al. m6A-driven NAT10 translation facilitates fatty acid metabolic rewiring to suppress ferroptosis and promote ovarian tumorigenesis through enhancing ACOT7 mRNA acetylation. Oncogene. 2024;43:3498-3516 pubmed publisher
Caggiano C, Petrera V, Ferri M, Pieraccioli M, Cesari E, Di Leone A, et al. Transient splicing inhibition causes persistent DNA damage and chemotherapy vulnerability in triple-negative breast cancer. Cell Rep. 2024;43:114751 pubmed publisher
Cao L, Lin G, Fan D, Weng K, Chen Y, Wang J, et al. NUAK1 activates STAT5/GLI1/SOX2 signaling to enhance cancer cell expansion and drives chemoresistance in gastric cancer. Cell Rep. 2024;43:114446 pubmed publisher
Khalil A, Smits D, Haughton P, Koorman T, Jansen K, Verhagen M, et al. A YAP-centered mechanotransduction loop drives collective breast cancer cell invasion. Nat Commun. 2024;15:4866 pubmed publisher
Desai A, Xiao A, Choi D, Toruner M, Walden D, Halfdanarson T, et al. Molecular Characterization and Therapeutic Opportunities in KRAS Wildtype Pancreatic Ductal Adenocarcinoma. Cancers (Basel). 2024;16: pubmed publisher
Dibitetto D, Liptay M, Vivalda F, Dogan H, Gogola E, Gonz xe1 lez Fern xe1 ndez M, et al. H2AX promotes replication fork degradation and chemosensitivity in BRCA-deficient tumours. Nat Commun. 2024;15:4430 pubmed publisher
Zhao Y, Wang H, Zhang S, Zhang W, Jiang Y, Shao Z. Enhancing therapeutic efficacy in luminal androgen receptor triple-negative breast cancer: exploring chidamide and enzalutamide as a promising combination strategy. Cancer Cell Int. 2024;24:131 pubmed publisher
Riddiough G, Fifis T, Muralidharan V, Christophi C, Tran B, Perini M, et al. Renin-Angiotensin Inhibitor, Captopril, Attenuates Growth of Patient-Derived Colorectal Liver Metastasis Organoids. Int J Mol Sci. 2024;25: pubmed publisher
Hrncir H, Bombin S, Goodloe B, Hogan C, Jadi O, Gracz A. Sox9 links biliary maturation to branching morphogenesis. bioRxiv. 2024;: pubmed publisher
Viergever B, Raats D, Geurts V, Mullenders J, Jonges T, Van Der Heijden M, et al. Urine-derived bladder cancer organoids (urinoids) as a tool for cancer longitudinal response monitoring and therapy adaptation. Br J Cancer. 2024;130:369-379 pubmed publisher
Chiriac M, Hracsko Z, Becker C, Neurath M. STAT2 Controls Colorectal Tumorigenesis and Resistance to Anti-Cancer Drugs. Cancers (Basel). 2023;15: pubmed publisher
Salahudeen A, Seoane J, Yuki K, Mah A, Smith A, Kolahi K, et al. Functional screening of amplification outlier oncogenes in organoid models of early tumorigenesis. Cell Rep. 2023;42:113355 pubmed publisher
Prekovic S, Chalkiadakis T, Roest M, Roden D, Lutz C, Schuurman K, et al. Luminal breast cancer identity is determined by loss of glucocorticoid receptor activity. EMBO Mol Med. 2023;15:e17737 pubmed publisher
Lin S, Sun Y, Cao C, Zhu Z, Xu Y, Liu B, et al. Single-nucleus RNA sequencing reveals heterogenous microenvironments and specific drug response between cervical squamous cell carcinoma and adenocarcinoma. EBioMedicine. 2023;97:104846 pubmed publisher
Yao L, Hao Q, Wang M, Chen Y, Cao H, Zhang Q, et al. KLHL29-mediated DDX3X degradation promotes chemosensitivity by abrogating cell cycle checkpoint in triple-negative breast cancer. Oncogene. 2023;42:3514-3528 pubmed publisher
Chan W, Mo X, Ip P, Tse K. Patient-derived organoid culture in epithelial ovarian cancers-Techniques, applications, and future perspectives. Cancer Med. 2023;12:19714-19731 pubmed publisher
de Kort W, Haakma W, van Es R, Gawlitta D, Driehuis E, Gansevoort M, et al. Jaw Bone Invasion of Oral Squamous Cell Carcinoma Is Associated with Osteoclast Count and Expression of Its Regulating Proteins in Patients and Organoids. J Clin Med. 2023;12: pubmed publisher
Skorda A, Lauridsen A, Wu C, Huang J, Mrackova M, Winther N, et al. Activation of invasion by oncogenic reprogramming of cholesterol metabolism via increased NPC1 expression and macropinocytosis. Oncogene. 2023;42:2495-2506 pubmed publisher
Lee H, Hwang M, Jang S, Um S. Immune Regulatory Function of Cancer- Associated Fibroblasts in Non-small Cell Lung Cancer. Tuberc Respir Dis (Seoul). 2023;86:304-318 pubmed publisher
McDonald H, Harper M, Hill K, Gao A, Solomon A, Bailey C, et al. Creation of EGD-Derived Gastric Cancer Organoids to Predict Treatment Responses. Cancers (Basel). 2023;15: pubmed publisher
Bhin J, Paes Dias M, Gogola E, Rolfs F, Piersma S, de Bruijn R, et al. Multi-omics analysis reveals distinct non-reversion mechanisms of PARPi resistance in BRCA1- versus BRCA2-deficient mammary tumors. Cell Rep. 2023;42:112538 pubmed publisher
Wit N, Gogola E, West J, Vornb xe4 umen T, Seear R, Bailey P, et al. A histone deacetylase 3 and mitochondrial complex I axis regulates toxic formaldehyde production. Sci Adv. 2023;9:eadg2235 pubmed publisher
Brundu S, Napolitano V, Franzolin G, Lo Cascio E, Mastrantonio R, Sardo G, et al. Mutated axon guidance gene PLXNB2 sustains growth and invasiveness of stem cells isolated from cancers of unknown primary. EMBO Mol Med. 2023;15:e16104 pubmed publisher
de Lange I, van Gorp C, Massy K, Kessels L, Kloosterboer N, Bj xf8 rnshave A, et al. Hypoxia-Driven Changes in a Human Intestinal Organoid Model and the Protective Effects of Hydrolyzed Whey. Nutrients. 2023;15: pubmed publisher
Luna Velez M, Neikes H, Snabel R, Quint Y, Qian C, Martens A, et al. ONECUT2 regulates RANKL-dependent enterocyte and microfold cell differentiation in the small intestine; a multi-omics study. Nucleic Acids Res. 2023;51:1277-1296 pubmed publisher
Caipa Garcia A, Kucab J, Al Serori H, Beck R, Fischer F, Hufnagel M, et al. Metabolic Activation of Benzo[a]pyrene by Human Tissue Organoid Cultures. Int J Mol Sci. 2022;24: pubmed publisher
Ng A, Zhang S, Mak V, Zhou Y, Yuen Y, Sharma R, et al. AKTIP loss is enriched in ERα-positive breast cancer for tumorigenesis and confers endocrine resistance. Cell Rep. 2022;41:111821 pubmed publisher
Ca xf1 ellas Socias A, Cortina C, Hernando Momblona X, Palomo Ponce S, Mulholland E, Turón G, et al. Metastatic recurrence in colorectal cancer arises from residual EMP1+ cells. Nature. 2022;611:603-613 pubmed publisher
van Leeuwen J, Ba Alawi W, Branchard E, Cruickshank J, Schormann W, Longo J, et al. Computational pharmacogenomic screen identifies drugs that potentiate the anti-breast cancer activity of statins. Nat Commun. 2022;13:6323 pubmed publisher
Spanjaard A, Shah R, de Groot D, Buoninfante O, Morris B, Lieftink C, et al. Division of labor within the DNA damage tolerance system reveals non-epistatic and clinically actionable targets for precision cancer medicine. Nucleic Acids Res. 2022;50:7420-7435 pubmed publisher
Diamantopoulou Z, Castro Giner F, Schwab F, Foerster C, Saini M, Budinjas S, et al. The metastatic spread of breast cancer accelerates during sleep. Nature. 2022;607:156-162 pubmed publisher
Hall A, Pohl S, Cammareri P, Aitken S, Younger N, Raponi M, et al. RNA splicing is a key mediator of tumour cell plasticity and a therapeutic vulnerability in colorectal cancer. Nat Commun. 2022;13:2791 pubmed publisher
Roos F, van Tienderen G, Wu H, Bordeu I, Vinke D, Albarinos L, et al. Human branching cholangiocyte organoids recapitulate functional bile duct formation. Cell Stem Cell. 2022;29:776-794.e13 pubmed publisher
Shah K, Maradana M, Joaquina Del xe0 s M, Metidji A, Graelmann F, Llorian M, et al. Cell-intrinsic Aryl Hydrocarbon Receptor signalling is required for the resolution of injury-induced colonic stem cells. Nat Commun. 2022;13:1827 pubmed publisher
Chen Y, Ge J, Zhu S, Shao Z, Yu K. Copy number amplification of ENSA promotes the progression of triple-negative breast cancer via cholesterol biosynthesis. Nat Commun. 2022;13:791 pubmed publisher
Xiao Y, Ma D, Yang Y, Yang F, Ding J, Gong Y, et al. Comprehensive metabolomics expands precision medicine for triple-negative breast cancer. Cell Res. 2022;32:477-490 pubmed publisher
Bollen Y, Hageman J, van Leenen P, Derks L, Ponsioen B, Buissant des Amorie J, et al. Efficient and error-free fluorescent gene tagging in human organoids without double-strand DNA cleavage. PLoS Biol. 2022;20:e3001527 pubmed publisher
Tran B, Grimley S, McAuley J, Hachani A, Earnest L, Wong S, et al. Air-Liquid-Interface Differentiated Human Nose Epithelium: A Robust Primary Tissue Culture Model of SARS-CoV-2 Infection. Int J Mol Sci. 2022;23: pubmed publisher
Choi B, Rawat V, H xf6 gstr xf6 m J, Burns P, Conger K, Ozgurses M, et al. Lineage-specific silencing of PSAT1 induces serine auxotrophy and sensitivity to dietary serine starvation in luminal breast tumors. Cell Rep. 2022;38:110278 pubmed publisher
van der Vaart J, Bosmans L, Sijbesma S, Knoops K, van de Wetering W, Otten H, et al. Adult mouse and human organoids derived from thyroid follicular cells and modeling of Graves' hyperthyroidism. Proc Natl Acad Sci U S A. 2021;118: pubmed publisher
Mathieu C, Touret F, Jacquemin C, Janin Y, Nougairede A, Brailly M, et al. A Bioluminescent 3CLPro Activity Assay to Monitor SARS-CoV-2 Replication and Identify Inhibitors. Viruses. 2021;13: pubmed publisher
Calandrini C, van Hooff S, Paassen I, Ayyildiz D, Derakhshan S, Dolman M, et al. Organoid-based drug screening reveals neddylation as therapeutic target for malignant rhabdoid tumors. Cell Rep. 2021;36:109568 pubmed publisher
Signati L, Allevi R, Piccotti F, Albasini S, Villani L, Sevieri M, et al. Ultrastructural analysis of breast cancer patient-derived organoids. Cancer Cell Int. 2021;21:423 pubmed publisher
De Bacco F, Orzan F, Erriquez J, Casanova E, Barault L, Albano R, et al. ERBB3 overexpression due to miR-205 inactivation confers sensitivity to FGF, metabolic activation, and liability to ERBB3 targeting in glioblastoma. Cell Rep. 2021;36:109455 pubmed publisher
Gudiño V, Pohl S, Billard C, Cammareri P, Bolado A, Aitken S, et al. RAC1B modulates intestinal tumourigenesis via modulation of WNT and EGFR signalling pathways. Nat Commun. 2021;12:2335 pubmed publisher
Gijzen L, Yousef Yengej F, Schutgens F, Vormann M, Ammerlaan C, Nicolas A, et al. Culture and analysis of kidney tubuloids and perfused tubuloid cells-on-a-chip. Nat Protoc. 2021;16:2023-2050 pubmed publisher
Yang M, Darwish T, Larraufie P, Rimmington D, Cimino I, Goldspink D, et al. Inhibition of mitochondrial function by metformin increases glucose uptake, glycolysis and GDF-15 release from intestinal cells. Sci Rep. 2021;11:2529 pubmed publisher
Tulasi D, Castaneda D, Wager K, Hogan C, Alcedo K, Raab J, et al. Sox9EGFP Defines Biliary Epithelial Heterogeneity Downstream of Yap Activity. Cell Mol Gastroenterol Hepatol. 2021;11:1437-1462 pubmed publisher
Yasuda S, Sumioka T, Iwanishi H, Okada Y, Miyajima M, Ichikawa K, et al. Loss of sphingosine 1-phosphate receptor 3 gene function impairs injury-induced stromal angiogenesis in mouse cornea. Lab Invest. 2021;101:245-257 pubmed publisher
Demmers L, Kretzschmar K, Van Hoeck A, Bar Epraïm Y, van den Toorn H, Koomen M, et al. Single-cell derived tumor organoids display diversity in HLA class I peptide presentation. Nat Commun. 2020;11:5338 pubmed publisher
Donato C, Kunz L, Castro Giner F, Paasinen Sohns A, Strittmatter K, Szczerba B, et al. Hypoxia Triggers the Intravasation of Clustered Circulating Tumor Cells. Cell Rep. 2020;32:108105 pubmed publisher
Clark R, Lee S, Qiao J, Chung D. Preclinical evaluation of the anti-tumor activity of pralatrexate in high-risk neuroblastoma cells. Oncotarget. 2020;11:3069-3077 pubmed publisher
Francica P, Mutlu M, Blomen V, Oliveira C, Nowicka Z, Trenner A, et al. Functional Radiogenetic Profiling Implicates ERCC6L2 in Non-homologous End Joining. Cell Rep. 2020;32:108068 pubmed publisher
Kahounov xe1 Z, Rem x161 xed k J, Fedr R, Bouchal J, Mi x10d kov xe1 A, Slab xe1 kov xe1 E, et al. Slug-expressing mouse prostate epithelial cells have increased stem cell potential. Stem Cell Res. 2020;46:101844 pubmed publisher
Driehuis E, Oosterom N, Heil S, Müller I, Lin M, Kolders S, et al. Patient-derived oral mucosa organoids as an in vitro model for methotrexate induced toxicity in pediatric acute lymphoblastic leukemia. PLoS ONE. 2020;15:e0231588 pubmed publisher
Rosenbluth J, Schackmann R, Gray G, Selfors L, Li C, Boedicker M, et al. Organoid cultures from normal and cancer-prone human breast tissues preserve complex epithelial lineages. Nat Commun. 2020;11:1711 pubmed publisher
Calandrini C, Schutgens F, Oka R, Margaritis T, Candelli T, Mathijsen L, et al. An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity. Nat Commun. 2020;11:1310 pubmed publisher
Driehuis E, Van Hoeck A, Moore K, Kolders S, Francies H, Gulersonmez M, et al. Pancreatic cancer organoids recapitulate disease and allow personalized drug screening. Proc Natl Acad Sci U S A. 2019;: pubmed publisher
Driehuis E, Kolders S, Spelier S, Lõhmussaar K, Willems S, Devriese L, et al. Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy. Cancer Discov. 2019;: pubmed publisher
Antas P, Novellasdemunt L, Kucharska A, Massie I, Carvalho J, Oukrif D, et al. SH3BP4 Regulates Intestinal Stem Cells and Tumorigenesis by Modulating β-Catenin Nuclear Localization. Cell Rep. 2019;26:2266-2273.e4 pubmed publisher
Fakhiri J, Schneider M, Puschhof J, Stanifer M, Schildgen V, Holderbach S, et al. Novel Chimeric Gene Therapy Vectors Based on Adeno-Associated Virus and Four Different Mammalian Bocaviruses. Mol Ther Methods Clin Dev. 2019;12:202-222 pubmed publisher
Szczerba B, Castro Giner F, Vetter M, Krol I, Gkountela S, Landin J, et al. Neutrophils escort circulating tumour cells to enable cell cycle progression. Nature. 2019;566:553-557 pubmed publisher
Brix D, Tvingsholm S, Hansen M, Clemmensen K, Ohman T, Siino V, et al. Release of transcriptional repression via ErbB2-induced, SUMO-directed phosphorylation of myeloid zinc finger-1 serine 27 activates lysosome redistribution and invasion. Oncogene. 2019;38:3170-3184 pubmed publisher
Sachs N, de Ligt J, Kopper O, Gogola E, Bounova G, Weeber F, et al. A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity. Cell. 2018;172:373-386.e10 pubmed publisher
Raghavan C, Nagaraj R. AGE-RAGE interaction in the TGF?2-mediated epithelial to mesenchymal transition of human lens epithelial cells. Glycoconj J. 2016;33:631-43 pubmed publisher
product information
master code :
3533-010-02
SKU :
3533-010-02
product name :
Cultrex RGF Basement Membrane Extract, Type 2
unit size :
10 mL (2 x 5 mL)
target :
Basement Membrane Extracts
category :
Cell Culture Products
buffer :
12 - 18 mg/mL.
details of functionality :
Functional Assay - Tube formation assay: BME promotes formation of capillary-like structures by human (HBMVEC; HUVEC) or mouse (SVEC4-10) endothelial cells. Gelling Assay - BME gels in less than 30 minutes at 37░C, and maintains the gelled form in culture medium for a minimum of 14 days at 37░C.
endotoxin note :
<8.0 EU per 1 ╡g of the protein by the LAL method.
top caption :
Mouse Intestinal Organoids Cultured in Cultrex RGF BME Type 2_3533-005-02
applications :
Bioactivity
extended description :
For Robust Organoid Cultures - Reduced Growth Factor Basement Membrane Extract
USD :
446 USD
product details :
For Robust Organoid Cultures - Reduced Growth Factor Basement Membrane Extract
storage :
Product is stable for a minimum of 3 months from date of shipment when stored at -20 ░C in a manual defrost freezer. For optimal stability, store at -80 ░C. Avoid freeze-thaw cycles. Storage Buffer: DulbeccoÆs Modified EagleÆs medium without phenol red, with 10 ug/ml gentamicin sulfate. Sterility Testing: PathClear« - Negative by PCR test for mycoplasma; 17 bacterial and virus strains typically included in mouse antibody production (MAP) testing, plus 13 additional murine infectious agents including LDEV, for a total of 31 organisms and viruses. No bacterial or fungal growth detected after incubation at 37 ░C for 14 days following USP sterility testing guidelines.
more info or order :
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.